Since 2016, when it was created from a vacant lot, the pocket park at 10th Street and Iris Avenue has been a peaceful place to sit and enjoy nature, sculptures, ...
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.
Boise-based SWEAR was honored by Fast Company’s 2025 Innovation by Design Awards for AI design and data design innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback